312 related articles for article (PubMed ID: 21454917)
1. Gabapentin combined with naltrexone for the treatment of alcohol dependence.
Anton RF; Myrick H; Wright TM; Latham PK; Baros AM; Waid LR; Randall PK
Am J Psychiatry; 2011 Jul; 168(7):709-17. PubMed ID: 21454917
[TBL] [Abstract][Full Text] [Related]
2. Gabapentin treatment for alcohol dependence: a randomized clinical trial.
Mason BJ; Quello S; Goodell V; Shadan F; Kyle M; Begovic A
JAMA Intern Med; 2014 Jan; 174(1):70-7. PubMed ID: 24190578
[TBL] [Abstract][Full Text] [Related]
3. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.
Brower KJ; Myra Kim H; Strobbe S; Karam-Hage MA; Consens F; Zucker RA
Alcohol Clin Exp Res; 2008 Aug; 32(8):1429-38. PubMed ID: 18540923
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.
Furieri FA; Nakamura-Palacios EM
J Clin Psychiatry; 2007 Nov; 68(11):1691-700. PubMed ID: 18052562
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence.
Schacht JP; Randall PK; Waid LR; Baros AM; Latham PK; Wright TM; Myrick H; Anton RF
Alcohol Clin Exp Res; 2011 Nov; 35(11):2030-8. PubMed ID: 21631542
[TBL] [Abstract][Full Text] [Related]
6. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
Myrick H; Anton R; Voronin K; Wang W; Henderson S
Alcohol Clin Exp Res; 2007 Feb; 31(2):221-7. PubMed ID: 17250613
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
[TBL] [Abstract][Full Text] [Related]
8. Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics.
Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
Psychopharmacology (Berl); 2013 Jun; 227(4):627-37. PubMed ID: 23389755
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
[TBL] [Abstract][Full Text] [Related]
10. Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.
Sanders NC; Mancino MJ; Gentry WB; Guise JB; Bickel WK; Thostenson J; Oliveto AH
Exp Clin Psychopharmacol; 2013 Aug; 21(4):294-302. PubMed ID: 23855333
[TBL] [Abstract][Full Text] [Related]
11. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
Myrick H; Malcolm R; Randall PK; Boyle E; Anton RF; Becker HC; Randall CL
Alcohol Clin Exp Res; 2009 Sep; 33(9):1582-8. PubMed ID: 19485969
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial.
O'Malley SS; Robin RW; Levenson AL; GreyWolf I; Chance LE; Hodgkinson CA; Romano D; Robinson J; Meandzija B; Stillner V; Wu R; Goldman D
Alcohol Clin Exp Res; 2008 Jul; 32(7):1271-83. PubMed ID: 18482155
[TBL] [Abstract][Full Text] [Related]
13. Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.
Mason BJ; Light JM; Williams LD; Drobes DJ
Addict Biol; 2009 Jan; 14(1):73-83. PubMed ID: 18855801
[TBL] [Abstract][Full Text] [Related]
14. The role of gabapentin in the management of alcohol withdrawal and dependence.
Leung JG; Hall-Flavin D; Nelson S; Schmidt KA; Schak KM
Ann Pharmacother; 2015 Aug; 49(8):897-906. PubMed ID: 25969570
[TBL] [Abstract][Full Text] [Related]
15. A randomized placebo-controlled trial of gabapentin for cocaine dependence.
Bisaga A; Aharonovich E; Garawi F; Levin FR; Rubin E; Raby WN; Nunes EV
Drug Alcohol Depend; 2006 Feb; 81(3):267-74. PubMed ID: 16169160
[TBL] [Abstract][Full Text] [Related]
16. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
[TBL] [Abstract][Full Text] [Related]
17. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
[TBL] [Abstract][Full Text] [Related]
19. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
